<rdf:RDF xmlns:api="http://www.elsevier.com/xml/svapi/rdf/dtd/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/38749089852"><dc:identifier>https://api.elsevier.com/content/abstract/eid/2-s2.0-38749089852</dc:identifier><api:scopusId>38749089852</api:scopusId><api:eid>2-s2.0-38749089852</api:eid><api:pubmedId>17504841</api:pubmedId><api:pui>351183308</api:pui><prism:doi>10.1136/ard.2007.070367</prism:doi><dc:title>EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics</dc:title><prism:issn>00034967</prism:issn><prism:contentType>Abstract</prism:contentType><prism:aggregationType>Journal</prism:aggregationType><api:srctype>j</api:srctype><api:subtype>ar</api:subtype><api:subtypeDescription>Article</api:subtypeDescription><api:citedbyCount>388</api:citedbyCount><prism:publicationName>Annals of the Rheumatic Diseases</prism:publicationName><api:sourceId>19136</api:sourceId><prism:volume>67</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:startingPage>195</prism:startingPage><prism:endingPage>205</prism:endingPage><prism:pageRange>195-205</prism:pageRange><prism:coverDate>2008-02-01</prism:coverDate><prism:copyrightYear>2008</prism:copyrightYear><dc:creator><rdf:Seq><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6602377310"><api:authid>6602377310</api:authid><api:surname>Bertsias</api:surname><api:givenName>G.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60012413"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/35377033000"><api:authid>35377033000</api:authid><api:surname>Ioannidis</api:surname><api:givenName>J. P.A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60029082"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7003661265"><api:authid>7003661265</api:authid><api:surname>Boletis</api:surname><api:givenName>J.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60024352"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7006270830"><api:authid>7006270830</api:authid><api:surname>Bombardieri</api:surname><api:givenName>S.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60028868"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/35374495300"><api:authid>35374495300</api:authid><api:surname>Cervera</api:surname><api:givenName>R.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60030315"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005903786"><api:authid>7005903786</api:authid><api:surname>Dostal</api:surname><api:givenName>C.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60008395"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/8741597600"><api:authid>8741597600</api:authid><api:surname>Font</api:surname><api:givenName>J.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60030315"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/57193777973"><api:authid>57193777973</api:authid><api:surname>Gilboe</api:surname><api:givenName>I. M.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60026108"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005187655"><api:authid>7005187655</api:authid><api:surname>Houssiau</api:surname><api:givenName>F.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60012936"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/16197605000"><api:authid>16197605000</api:authid><api:surname>Huizinga</api:surname><api:givenName>T.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60015618"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/36051280800"><api:authid>36051280800</api:authid><api:surname>Isenberg</api:surname><api:givenName>D.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60022148"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/35395889100"><api:authid>35395889100</api:authid><api:surname>Kallenberg</api:surname><api:givenName>C. G.M.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60006027"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/35378654100"><api:authid>35378654100</api:authid><api:surname>Khamashta</api:surname><api:givenName>M.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60022148"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7202564680"><api:authid>7202564680</api:authid><api:surname>Piette</api:surname><api:givenName>J. C.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60015622"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7404064148"><api:authid>7404064148</api:authid><api:surname>Schneider</api:surname><api:givenName>M.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60025310"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7103202523"><api:authid>7103202523</api:authid><api:surname>Smolen</api:surname><api:givenName>J.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60011394"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7007138118"><api:authid>7007138118</api:authid><api:surname>Sturfelt</api:surname><api:givenName>G.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60014077"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005623740"><api:authid>7005623740</api:authid><api:surname>Tincani</api:surname><api:givenName>A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/100719676"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7004564883"><api:authid>7004564883</api:authid><api:surname>Van Vollenhoven</api:surname><api:givenName>R.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60019295"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7401477337"><api:authid>7401477337</api:authid><api:surname>Gordon</api:surname><api:givenName>C.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60019702"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7007045263"><api:authid>7007045263</api:authid><api:surname>Boumpas</api:surname><api:givenName>D. T.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60012413"/><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60012413"/></api:Author></rdf:li></rdf:Seq></dc:creator><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2745"/><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2723"/><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2403"/><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/1300"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0025372094"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029004818"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029037063"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0003454465"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/4344622733"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034028877"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/10444279147"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/1442348282"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034800173"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0141891339"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036892104"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0027976583"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035673615"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034087160"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033848873"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/27744548883"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/14144250125"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0037809612"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0346688744"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/8844244629"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0024501514"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034090671"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034562189"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029125512"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/9144234103"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0031793798"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2942748316"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/4243120895"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029853168"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034059382"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036240019"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034992769"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034515433"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/23944498855"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034757875"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036222879"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034756741"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/23444440507"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029147377"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0022573072"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/38749138857"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029020939"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029013185"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0032909948"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/22644444146"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/11144353881"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0242495176"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0347922145"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/24944496938"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/1842530440"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034030376"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035086404"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/20844443482"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0028110390"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0026074414"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/6844255888"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033000295"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0016770049"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0015928898"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033663693"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33344458573"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0027159807"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/8944261594"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/23844550570"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33745243801"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0030967338"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/28944445445"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/28944431771"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2442480486"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/20544443248"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2442570098"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034004327"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035864904"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029125306"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0026592028"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/31044445706"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029072993"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/1342325729"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/20144387997"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2642709239"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0037269573"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029804117"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2942654762"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036024148"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0027094294"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0025900754"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036273040"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0025301272"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0027321013"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034810266"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035702735"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0042521155"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0032726750"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0027255761"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0022888665"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0024393524"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0025789676"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0031745967"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0028585841"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034990187"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0027303844"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0031046401"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0028908094"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033386110"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0037182043"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034655760"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0141791073"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/23844437705"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0028304089"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0026659095"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/84921705962"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0017350006"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0021137695"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036099111"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034989491"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0029089379"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/10444275010"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0345352680"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0030268581"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2942731474"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0742278571"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0022578857"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035928643"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0026767866"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/25444432233"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034687429"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/20444466207"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/28144433147"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/28444437000"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/1442355581"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/32444443319"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/38749143287"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/28544449032"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034007121"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/13444259472"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0030198652"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0021733803"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0020620634"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035884699"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0037673312"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/26944451361"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034021145"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0032401856"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033013573"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0036899604"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033518231"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77953582870"/><api:scopusPage rdf:resource="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=38749089852&amp;origin=inward"/></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60012413"><api:afid>60012413</api:afid><skos:prefLabel>University of Crete Medical School</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60029082"><api:afid>60029082</api:afid><skos:prefLabel>University of Ioannina, School of Medicine</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60024352"><api:afid>60024352</api:afid><skos:prefLabel>Laikon General Hospital</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60028868"><api:afid>60028868</api:afid><skos:prefLabel>Universita di Pisa</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60030315"><api:afid>60030315</api:afid><skos:prefLabel>Hospital Clinic Barcelona</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60008395"><api:afid>60008395</api:afid><skos:prefLabel>Institute of Rheumatology</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60026108"><api:afid>60026108</api:afid><skos:prefLabel>Rikshospitalet-Radiumhospitalet HF</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60012936"><api:afid>60012936</api:afid><skos:prefLabel>Cliniques Universitaires Saint-Luc, Brussels</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60015618"><api:afid>60015618</api:afid><skos:prefLabel>Leiden University Medical Center - LUMC</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60022148"><api:afid>60022148</api:afid><skos:prefLabel>UCL</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60006027"><api:afid>60006027</api:afid><skos:prefLabel>University of Groningen, University Medical Center Groningen</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60022148"><api:afid>60022148</api:afid><skos:prefLabel>UCL</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60015622"><api:afid>60015622</api:afid><skos:prefLabel>Hopital Pitie Salpetriere</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60025310"><api:afid>60025310</api:afid><skos:prefLabel>Heinrich Heine Universitat</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60011394"><api:afid>60011394</api:afid><skos:prefLabel>Medizinische Universitat Wien</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60014077"><api:afid>60014077</api:afid><skos:prefLabel>Sk√•nes universitetssjukhus</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/100719676"><api:afid>100719676</api:afid><skos:prefLabel>Ospedale Civile di Brescia</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60019295"><api:afid>60019295</api:afid><skos:prefLabel>Karolinska University Hospital</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60019702"><api:afid>60019702</api:afid><skos:prefLabel>University of Birmingham</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60012413"><api:afid>60012413</api:afid><skos:prefLabel>University of Crete Medical School</skos:prefLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2745"><api:code>2745</api:code><api:abbrev>MEDI</api:abbrev><skos:prefLabel>Rheumatology</skos:prefLabel><skos:altLabel>Medicine</skos:altLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2723"><api:code>2723</api:code><api:abbrev>MEDI</api:abbrev><skos:prefLabel>Immunology and Allergy</skos:prefLabel><skos:altLabel>Medicine</skos:altLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2403"><api:code>2403</api:code><api:abbrev>IMMU</api:abbrev><skos:prefLabel>Immunology</skos:prefLabel><skos:altLabel>Immunology and Microbiology</skos:altLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/1300"><api:code>1300</api:code><api:abbrev>BIOC</api:abbrev><skos:prefLabel>Biochemistry, Genetics and Molecular Biology (all)</skos:prefLabel><skos:altLabel>Biochemistry, Genetics and Molecular Biology</skos:altLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0025372094"><api:scopusId>0025372094</api:scopusId><dc:title>Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval</dc:title><prism:publicationName>Br J Rheumatol</prism:publicationName><prism:publicationYear>1990</prism:publicationYear><prism:volume>29</prism:volume><prism:startingPage>185</prism:startingPage><prism:endingPage>188</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029004818"><api:scopusId>0029004818</api:scopusId><dc:title>Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>122</prism:volume><prism:startingPage>940</prism:startingPage><prism:endingPage>950</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029037063"><api:scopusId>0029037063</api:scopusId><dc:title>Systemic lupus erythematosus: Emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>123</prism:volume><prism:startingPage>42</prism:startingPage><prism:endingPage>53</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0003454465"><api:scopusId>0003454465</api:scopusId><prism:publicationName>Guidelines for clinical practice: From development to use</prism:publicationName><prism:publicationYear>1992</prism:publicationYear></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/4344622733"><api:scopusId>4344622733</api:scopusId><dc:title>EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>63</prism:volume><prism:startingPage>1172</prism:startingPage><prism:endingPage>1176</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034028877"><api:scopusId>0034028877</api:scopusId><dc:title>A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>39</prism:volume><prism:startingPage>399</prism:startingPage><prism:endingPage>406</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/10444279147"><api:scopusId>10444279147</api:scopusId><dc:title>Predictors of neuropsychiatric damage in systemic lupus erythematosus: Data from the Maryland lupus cohort</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>43</prism:volume><prism:startingPage>1555</prism:startingPage><prism:endingPage>1560</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/1442348282"><api:scopusId>1442348282</api:scopusId><dc:title>Clusters of clinical and immunologic features in systemic lupus erythematosus: Analysis of 600 patients from a single center</dc:title><prism:publicationName>Semin Arthritis Rheum</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>33</prism:volume><prism:startingPage>217</prism:startingPage><prism:endingPage>230</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034800173"><api:scopusId>0034800173</api:scopusId><dc:title>Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>45</prism:volume><prism:startingPage>191</prism:startingPage><prism:endingPage>202</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0141891339"><api:scopusId>0141891339</api:scopusId><dc:title>Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients</dc:title><prism:publicationName>Medicine (Baltimore)</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>82</prism:volume><prism:startingPage>299</prism:startingPage><prism:endingPage>308</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036892104"><api:scopusId>0036892104</api:scopusId><dc:title>Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>61</prism:volume><prism:startingPage>1065</prism:startingPage><prism:endingPage>1070</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0027976583"><api:scopusId>0027976583</api:scopusId><dc:title>Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data</dc:title><prism:publicationName>Kidney Int</prism:publicationName><prism:publicationYear>1994</prism:publicationYear><prism:volume>45</prism:volume><prism:startingPage>544</prism:startingPage><prism:endingPage>550</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035673615"><api:scopusId>0035673615</api:scopusId><dc:title>Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>2797</prism:startingPage><prism:endingPage>2806</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034087160"><api:scopusId>0034087160</api:scopusId><dc:title>Hopkins Lupus Cohort. 1999 update</dc:title><prism:publicationName>Rheum Dis Clin North Am</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>26</prism:volume><prism:startingPage>199</prism:startingPage><prism:endingPage>213</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033848873"><api:scopusId>0033848873</api:scopusId><dc:title>Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>27</prism:volume><prism:startingPage>1892</prism:startingPage><prism:endingPage>1895</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/27744548883"><api:scopusId>27744548883</api:scopusId><dc:title>Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>32</prism:volume><prism:startingPage>2150</prism:startingPage><prism:endingPage>2155</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/14144250125"><api:scopusId>14144250125</api:scopusId><dc:title>Anti-C1q antibodies in nephritis: Correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>64</prism:volume><prism:startingPage>444</prism:startingPage><prism:endingPage>448</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0037809612"><api:scopusId>0037809612</api:scopusId><dc:title>Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: Significant factors associated with lupus nephritis</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>62</prism:volume><prism:startingPage>556</prism:startingPage><prism:endingPage>560</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0346688744"><api:scopusId>0346688744</api:scopusId><dc:title>High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus</dc:title><prism:publicationName>Arch Intern Med</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>164</prism:volume><prism:startingPage>77</prism:startingPage><prism:endingPage>82</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/8844244629"><api:scopusId>8844244629</api:scopusId><dc:title>Epileptic seizures in systemic lupus erythematosus</dc:title><prism:publicationName>Neurology</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>63</prism:volume><prism:startingPage>1808</prism:startingPage><prism:endingPage>1812</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0024501514"><api:scopusId>0024501514</api:scopusId><dc:title>Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1989</prism:publicationYear><prism:volume>32</prism:volume><prism:startingPage>202</prism:startingPage><prism:endingPage>204</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034090671"><api:scopusId>0034090671</api:scopusId><dc:title>Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group</dc:title><prism:publicationName>Am J Kidney Dis</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>35</prism:volume><prism:startingPage>904</prism:startingPage><prism:endingPage>914</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034562189"><api:scopusId>0034562189</api:scopusId><dc:title>Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus</dc:title><prism:publicationName>Am J Med</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>109</prism:volume><prism:startingPage>628</prism:startingPage><prism:endingPage>634</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029125512"><api:scopusId>0029125512</api:scopusId><dc:title>High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients</dc:title><prism:publicationName>Nephrol Dial Transplant</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>10</prism:volume><prism:startingPage>1620</prism:startingPage><prism:endingPage>1628</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/9144234103"><api:scopusId>9144234103</api:scopusId><dc:title>Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis</dc:title><prism:publicationName>Am J Kidney Dis</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>43</prism:volume><prism:startingPage>28</prism:startingPage><prism:endingPage>36</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0031793798"><api:scopusId>0031793798</api:scopusId><dc:title>Measures of disease activity and damage in SLE</dc:title><prism:publicationName>Baillieres Clin Rheumatol</prism:publicationName><prism:publicationYear>1998</prism:publicationYear><prism:volume>12</prism:volume><prism:startingPage>405</prism:startingPage><prism:endingPage>413</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2942748316"><api:scopusId>2942748316</api:scopusId><dc:title>Clinical trial design in systemic lupus erythematosus: Lessons learned and future directions</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>13</prism:volume><prism:startingPage>406</prism:startingPage><prism:endingPage>411</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/4243120895"><api:scopusId>4243120895</api:scopusId><dc:title>Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus - a 5-yr prospective study</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>43</prism:volume><prism:startingPage>1039</prism:startingPage><prism:endingPage>1044</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029853168"><api:scopusId>0029853168</api:scopusId><dc:title>Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>1996</prism:publicationYear><prism:volume>55</prism:volume><prism:startingPage>756</prism:startingPage><prism:endingPage>760</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034059382"><api:scopusId>0034059382</api:scopusId><dc:title>Comparison of the validity and sensitivity to change of 5 activity indices in systemic fupus erythematosus</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>27</prism:volume><prism:startingPage>664</prism:startingPage><prism:endingPage>670</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036240019"><api:scopusId>0036240019</api:scopusId><dc:title>Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians</dc:title><prism:publicationName>J Clin Epidemiol</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>55</prism:volume><prism:startingPage>488</prism:startingPage><prism:endingPage>497</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034992769"><api:scopusId>0034992769</api:scopusId><dc:title>Skin lesions - an indicator of disease activity in systemic lupus erythematosus?</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>10</prism:volume><prism:startingPage>364</prism:startingPage><prism:endingPage>367</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034515433"><api:scopusId>0034515433</api:scopusId><dc:title>Prognostic parameters for flare in systemic lupus erythematosus</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>39</prism:volume><prism:startingPage>1316</prism:startingPage><prism:endingPage>1319</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/23944498855"><api:scopusId>23944498855</api:scopusId><dc:title>Lupus thrombocytopenia: Clinical implications and prognostic significance</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>64</prism:volume><prism:startingPage>1366</prism:startingPage><prism:endingPage>1369</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034757875"><api:scopusId>0034757875</api:scopusId><dc:title>A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>2350</prism:startingPage><prism:endingPage>2357</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036222879"><api:scopusId>0036222879</api:scopusId><dc:title>Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long-term followup of a cohort of 145 patients participating in randomized controlled studies</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>46</prism:volume><prism:startingPage>995</prism:startingPage><prism:endingPage>1002</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034756741"><api:scopusId>0034756741</api:scopusId><dc:title>Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>2342</prism:startingPage><prism:endingPage>2349</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/23444440507"><api:scopusId>23444440507</api:scopusId><dc:title>Prolonged remission in systemic lupus erythematosus</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>32</prism:volume><prism:startingPage>1467</prism:startingPage><prism:endingPage>1472</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029147377"><api:scopusId>0029147377</api:scopusId><dc:title>Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus</dc:title><prism:publicationName>Am J Kidney Dis</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>26</prism:volume><prism:startingPage>595</prism:startingPage><prism:endingPage>601</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0022573072"><api:scopusId>0022573072</api:scopusId><dc:title>Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>1986</prism:publicationYear><prism:volume>45</prism:volume><prism:startingPage>359</prism:startingPage><prism:endingPage>366</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/38749138857"><api:scopusId>38749138857</api:scopusId></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029020939"><api:scopusId>0029020939</api:scopusId><dc:title>Prevention of relapses in systemic lupus erythematosus</dc:title><prism:publicationName>Lancet</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>345</prism:volume><prism:startingPage>1595</prism:startingPage><prism:endingPage>1599</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029013185"><api:scopusId>0029013185</api:scopusId><dc:title>Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>22</prism:volume><prism:startingPage>1265</prism:startingPage><prism:endingPage>1270</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0032909948"><api:scopusId>0032909948</api:scopusId><dc:title>Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus</dc:title><prism:publicationName>Scand J Rheumatol</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>28</prism:volume><prism:startingPage>75</prism:startingPage><prism:endingPage>80</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/22644444146"><api:scopusId>22644444146</api:scopusId><dc:title>Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups</dc:title><prism:publicationName>Medicine (Baltimore)</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>84</prism:volume><prism:startingPage>218</prism:startingPage><prism:endingPage>224</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/11144353881"><api:scopusId>11144353881</api:scopusId><dc:title>Urinary tract infections and lupus erythematosus</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>63</prism:volume><prism:startingPage>431</prism:startingPage><prism:endingPage>437</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0242495176"><api:scopusId>0242495176</api:scopusId><dc:title>Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>48</prism:volume><prism:startingPage>3159</prism:startingPage><prism:endingPage>3167</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0347922145"><api:scopusId>0347922145</api:scopusId><dc:title>Premature coronary-artery atherosclerosis in systemic lupus erythematosus</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>349</prism:volume><prism:startingPage>2407</prism:startingPage><prism:endingPage>2415</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/24944496938"><api:scopusId>24944496938</api:scopusId><dc:title>Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>756</prism:startingPage><prism:endingPage>761</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/1842530440"><api:scopusId>1842530440</api:scopusId><dc:title>Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: Results from a Swedish population based study 1964-95</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>31</prism:volume><prism:startingPage>713</prism:startingPage><prism:endingPage>719</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034030376"><api:scopusId>0034030376</api:scopusId><dc:title>Bone mineral density in systemic lupus erythematosus: Comparison with rheumatoid arthritis and healthy controls</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>59</prism:volume><prism:startingPage>110</prism:startingPage><prism:endingPage>115</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035086404"><api:scopusId>0035086404</api:scopusId><dc:title>Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>28</prism:volume><prism:startingPage>761</prism:startingPage><prism:endingPage>765</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/20844443482"><api:scopusId>20844443482</api:scopusId><dc:title>An international cohort study of cancer in systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>1481</prism:startingPage><prism:endingPage>1490</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0028110390"><api:scopusId>0028110390</api:scopusId><dc:title>Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1994</prism:publicationYear><prism:volume>37</prism:volume><prism:startingPage>1311</prism:startingPage><prism:endingPage>1320</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0026074414"><api:scopusId>0026074414</api:scopusId><dc:title>A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1991</prism:publicationYear><prism:volume>324</prism:volume><prism:startingPage>150</prism:startingPage><prism:endingPage>154</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/6844255888"><api:scopusId>6844255888</api:scopusId><dc:title>A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>1998</prism:publicationYear><prism:volume>7</prism:volume><prism:startingPage>80</prism:startingPage><prism:endingPage>85</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033000295"><api:scopusId>0033000295</api:scopusId><dc:title>Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>26</prism:volume><prism:startingPage>1275</prism:startingPage><prism:endingPage>1279</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0016770049"><api:scopusId>0016770049</api:scopusId><dc:title>Long-term maintenance therapy with azathioprine in systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1975</prism:publicationYear><prism:volume>18</prism:volume><prism:startingPage>27</prism:startingPage><prism:endingPage>34</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0015928898"><api:scopusId>0015928898</api:scopusId><dc:title>Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1973</prism:publicationYear><prism:volume>288</prism:volume><prism:startingPage>122</prism:startingPage><prism:endingPage>124</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033663693"><api:scopusId>0033663693</api:scopusId><dc:title>Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test</dc:title><prism:publicationName>Photodermatol Photoimmunol Photomed</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>16</prism:volume><prism:startingPage>256</prism:startingPage><prism:endingPage>259</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33344458573"><api:scopusId>33344458573</api:scopusId><dc:title>International consesus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)</dc:title><prism:publicationName>J Thromb Haemostasis</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>4</prism:volume><prism:startingPage>295</prism:startingPage><prism:endingPage>306</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0027159807"><api:scopusId>0027159807</api:scopusId><dc:title>Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1993</prism:publicationYear><prism:volume>328</prism:volume><prism:startingPage>1747</prism:startingPage><prism:endingPage>1752</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/8944261594"><api:scopusId>8944261594</api:scopusId><dc:title>Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: A 3 year followup</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1996</prism:publicationYear><prism:volume>23</prism:volume><prism:startingPage>995</prism:startingPage><prism:endingPage>1000</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/23844550570"><api:scopusId>23844550570</api:scopusId><dc:title>Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>14</prism:volume><prism:startingPage>517</prism:startingPage><prism:endingPage>520</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33745243801"><api:scopusId>33745243801</api:scopusId><dc:title>Anti-inflammatory and immunosuppressive drugs and reproduction</dc:title><prism:publicationName>Arthritis Res Ther</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>8</prism:volume><prism:startingPage>209</prism:startingPage><prism:endingPage>228</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0030967338"><api:scopusId>0030967338</api:scopusId><dc:title>Past use of oral contraceptives and the risk of developing systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1997</prism:publicationYear><prism:volume>40</prism:volume><prism:startingPage>804</prism:startingPage><prism:endingPage>808</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/28944445445"><api:scopusId>28944445445</api:scopusId><dc:title>Combined oral contraceptives in women with systemic lupus erythematosus</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>353</prism:volume><prism:startingPage>2550</prism:startingPage><prism:endingPage>2558</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/28944431771"><api:scopusId>28944431771</api:scopusId><dc:title>A trial of contraceptive methods in women with systemic lupus erythematosus</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>353</prism:volume><prism:startingPage>2539</prism:startingPage><prism:endingPage>2549</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2442480486"><api:scopusId>2442480486</api:scopusId><dc:title>The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial</dc:title><prism:publicationName>Osteoporos Int</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>15</prism:volume><prism:startingPage>396</prism:startingPage><prism:endingPage>404</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/20544443248"><api:scopusId>20544443248</api:scopusId><dc:title>The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>142</prism:volume><prism:startingPage>953</prism:startingPage><prism:endingPage>962</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2442570098"><api:scopusId>2442570098</api:scopusId><dc:title>A meta-analysis for headache in systemic lupus erythematosus: The evidence and the myth</dc:title><prism:publicationName>Brain</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>127</prism:volume><prism:startingPage>1200</prism:startingPage><prism:endingPage>1209</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034004327"><api:scopusId>0034004327</api:scopusId><dc:title>Cognitive impairment in systemic lupus erythematosus: A follow-up study</dc:title><prism:publicationName>J Neurol</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>247</prism:volume><prism:startingPage>273</prism:startingPage><prism:endingPage>279</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035864904"><api:scopusId>0035864904</api:scopusId><dc:title>Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations</dc:title><prism:publicationName>J Neurol Sci</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>184</prism:volume><prism:startingPage>33</prism:startingPage><prism:endingPage>39</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029125306"><api:scopusId>0029125306</api:scopusId><dc:title>Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests</dc:title><prism:publicationName>Am J Med</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>99</prism:volume><prism:startingPage>153</prism:startingPage><prism:endingPage>163</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0026592028"><api:scopusId>0026592028</api:scopusId><dc:title>Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1992</prism:publicationYear><prism:volume>35</prism:volume><prism:startingPage>1330</prism:startingPage><prism:endingPage>1342</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/31044445706"><api:scopusId>31044445706</api:scopusId><dc:title>Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta-analysis</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>54</prism:volume><prism:startingPage>312</prism:startingPage><prism:endingPage>324</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029072993"><api:scopusId>0029072993</api:scopusId><dc:title>The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>22</prism:volume><prism:startingPage>1247</prism:startingPage><prism:endingPage>1253</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/1342325729"><api:scopusId>1342325729</api:scopusId><dc:title>Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance</dc:title><prism:publicationName>Neuroradiology</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>46</prism:volume><prism:startingPage>15</prism:startingPage><prism:endingPage>21</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/20144387997"><api:scopusId>20144387997</api:scopusId><dc:title>Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus</dc:title><prism:publicationName>Ann Rheum Dis</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>64</prism:volume><prism:startingPage>620</prism:startingPage><prism:endingPage>625</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2642709239"><api:scopusId>2642709239</api:scopusId><dc:title>Acute transverse myelopathy in systemic lupus erythematosus: Clinical presentation, treatment, and outcome</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1998</prism:publicationYear><prism:volume>25</prism:volume><prism:startingPage>467</prism:startingPage><prism:endingPage>473</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0037269573"><api:scopusId>0037269573</api:scopusId><dc:title>Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study)</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>12</prism:volume><prism:startingPage>3</prism:startingPage><prism:endingPage>7</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029804117"><api:scopusId>0029804117</api:scopusId><dc:title>Antiphospholipid antibodies and human reproductive failure</dc:title><prism:publicationName>Hum Reprod</prism:publicationName><prism:publicationYear>1996</prism:publicationYear><prism:volume>11</prism:volume><prism:startingPage>2310</prism:startingPage><prism:endingPage>2315</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2942654762"><api:scopusId>2942654762</api:scopusId><dc:title>Undiagnosed systemic lupus erythematosus in a cohort of infertile women</dc:title><prism:publicationName>Am J Reprod Immunol</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>51</prism:volume><prism:startingPage>336</prism:startingPage><prism:endingPage>340</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036024148"><api:scopusId>0036024148</api:scopusId><dc:title>Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>11</prism:volume><prism:startingPage>419</prism:startingPage><prism:endingPage>425</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0027094294"><api:scopusId>0027094294</api:scopusId><dc:title>The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome</dc:title><prism:publicationName>Am J Reprod Immunol</prism:publicationName><prism:publicationYear>1992</prism:publicationYear><prism:volume>28</prism:volume><prism:startingPage>199</prism:startingPage><prism:endingPage>204</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0025900754"><api:scopusId>0025900754</api:scopusId><dc:title>Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1991</prism:publicationYear><prism:volume>34</prism:volume><prism:startingPage>937</prism:startingPage><prism:endingPage>944</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036273040"><api:scopusId>0036273040</api:scopusId><dc:title>Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>41</prism:volume><prism:startingPage>643</prism:startingPage><prism:endingPage>650</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0025301272"><api:scopusId>0025301272</api:scopusId><dc:title>Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1990</prism:publicationYear><prism:volume>17</prism:volume><prism:startingPage>771</prism:startingPage><prism:endingPage>776</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0027321013"><api:scopusId>0027321013</api:scopusId><dc:title>Pregnancy in lupus nephropathy</dc:title><prism:publicationName>Acta Obstet Gynecol Scand</prism:publicationName><prism:publicationYear>1993</prism:publicationYear><prism:volume>72</prism:volume><prism:startingPage>258</prism:startingPage><prism:endingPage>263</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034810266"><api:scopusId>0034810266</api:scopusId><dc:title>Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis</dc:title><prism:publicationName>Am J Reprod Immunol</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>46</prism:volume><prism:startingPage>274</prism:startingPage><prism:endingPage>279</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035702735"><api:scopusId>0035702735</api:scopusId><dc:title>Pregnancy outcomes in women with systemic lupus erythematosus</dc:title><prism:publicationName>J Matern Fetal Med</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>10</prism:volume><prism:startingPage>91</prism:startingPage><prism:endingPage>96</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0042521155"><api:scopusId>0042521155</api:scopusId><dc:title>The risk of pregnancy in patients with lupus nephritis</dc:title><prism:publicationName>J Nephrol</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>16</prism:volume><prism:startingPage>161</prism:startingPage><prism:endingPage>167</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0032726750"><api:scopusId>0032726750</api:scopusId><dc:title>Pregnancy outcome and family size in systemic lupus erythematosus: A case-control study</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>38</prism:volume><prism:startingPage>559</prism:startingPage><prism:endingPage>563</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0027255761"><api:scopusId>0027255761</api:scopusId><dc:title>Fetal outcome in lupus pregnancy: A retrospective case-control study of 242 pregnancies in 112 patients</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>1993</prism:publicationYear><prism:volume>2</prism:volume><prism:startingPage>125</prism:startingPage><prism:endingPage>131</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0022888665"><api:scopusId>0022888665</api:scopusId><dc:title>Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1986</prism:publicationYear><prism:volume>13</prism:volume><prism:startingPage>732</prism:startingPage><prism:endingPage>739</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0024393524"><api:scopusId>0024393524</api:scopusId><dc:title>The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population</dc:title><prism:publicationName>Am J Obstet Gynecol</prism:publicationName><prism:publicationYear>1989</prism:publicationYear><prism:volume>161</prism:volume><prism:startingPage>369</prism:startingPage><prism:endingPage>373</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0025789676"><api:scopusId>0025789676</api:scopusId><dc:title>The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction</dc:title><prism:publicationName>Obstet Gynecol</prism:publicationName><prism:publicationYear>1991</prism:publicationYear><prism:volume>78</prism:volume><prism:startingPage>1108</prism:startingPage><prism:endingPage>1111</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0031745967"><api:scopusId>0031745967</api:scopusId><dc:title>Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry</dc:title><prism:publicationName>J Am Coll Cardiol</prism:publicationName><prism:publicationYear>1998</prism:publicationYear><prism:volume>31</prism:volume><prism:startingPage>1658</prism:startingPage><prism:endingPage>1666</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0028585841"><api:scopusId>0028585841</api:scopusId><dc:title>Pregnancy and its outcome in systemic lupus erythematosus</dc:title><prism:publicationName>OJM</prism:publicationName><prism:publicationYear>1994</prism:publicationYear><prism:volume>87</prism:volume><prism:startingPage>721</prism:startingPage><prism:endingPage>729</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034990187"><api:scopusId>0034990187</api:scopusId><dc:title>Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>10</prism:volume><prism:startingPage>401</prism:startingPage><prism:endingPage>404</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0027303844"><api:scopusId>0027303844</api:scopusId><dc:title>Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>1993</prism:publicationYear><prism:volume>20</prism:volume><prism:startingPage>1152</prism:startingPage><prism:endingPage>1157</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0031046401"><api:scopusId>0031046401</api:scopusId><dc:title>Immunosuppressive drug use during pregnancy</dc:title><prism:publicationName>Rheum Dis Clin North Am</prism:publicationName><prism:publicationYear>1997</prism:publicationYear><prism:volume>23</prism:volume><prism:startingPage>149</prism:startingPage><prism:endingPage>167</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0028908094"><api:scopusId>0028908094</api:scopusId><dc:title>The management of thrombosis in the antiphospholipid-antibody syndrome</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>332</prism:volume><prism:startingPage>993</prism:startingPage><prism:endingPage>997</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033386110"><api:scopusId>0033386110</api:scopusId><dc:title>Clinical study and follow-up of 100 patients with the antiphospholipid syndrome</dc:title><prism:publicationName>Semin Arthritis Rheum</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>29</prism:volume><prism:startingPage>182</prism:startingPage><prism:endingPage>190</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0037182043"><api:scopusId>0037182043</api:scopusId><dc:title>Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: Analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5</dc:title><prism:publicationName>Arch Intern Med</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>162</prism:volume><prism:startingPage>1164</prism:startingPage><prism:endingPage>1169</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034655760"><api:scopusId>0034655760</api:scopusId><dc:title>Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: A multicenter study</dc:title><prism:publicationName>Transplantation</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>69</prism:volume><prism:startingPage>1348</prism:startingPage><prism:endingPage>1352</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0141791073"><api:scopusId>0141791073</api:scopusId><dc:title>A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>349</prism:volume><prism:startingPage>1133</prism:startingPage><prism:endingPage>1138</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/23844437705"><api:scopusId>23844437705</api:scopusId><dc:title>A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)</dc:title><prism:publicationName>J Thromb Haemost</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>3</prism:volume><prism:startingPage>848</prism:startingPage><prism:endingPage>853</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0028304089"><api:scopusId>0028304089</api:scopusId><dc:title>Thrombosis and antiphospholipid syndrome: A preliminary assessment of three antithrombotic treatments</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>1994</prism:publicationYear><prism:volume>3</prism:volume><prism:startingPage>85</prism:startingPage><prism:endingPage>90</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0026659095"><api:scopusId>0026659095</api:scopusId><dc:title>Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1992</prism:publicationYear><prism:volume>117</prism:volume><prism:startingPage>303</prism:startingPage><prism:endingPage>308</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/84921705962"><api:scopusId>84921705962</api:scopusId><dc:title>Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant</dc:title><prism:publicationName>Cochrane Database Syst Rev</prism:publicationName><prism:publicationYear>2005</prism:publicationYear></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0017350006"><api:scopusId>0017350006</api:scopusId><dc:title>Lupus nephritis. Clinical course as related to morphologic forms and their transitions</dc:title><prism:publicationName>Am J Med</prism:publicationName><prism:publicationYear>1977</prism:publicationYear><prism:volume>62</prism:volume><prism:startingPage>12</prism:startingPage><prism:endingPage>30</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0021137695"><api:scopusId>0021137695</api:scopusId><dc:title>Effect of treatment on the evolution of renal abnormalities in lupus nephritis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1984</prism:publicationYear><prism:volume>311</prism:volume><prism:startingPage>491</prism:startingPage><prism:endingPage>495</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036099111"><api:scopusId>0036099111</api:scopusId><dc:title>Outcome of relapse in lupus nephritis: Roles of reversal of renal fibrosis and response of inflammation to therapy</dc:title><prism:publicationName>Kidney Int</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>61</prism:volume><prism:startingPage>2176</prism:startingPage><prism:endingPage>2186</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034989491"><api:scopusId>0034989491</api:scopusId><dc:title>Significance of isolated hematuria and isolated puyria in systemic lupus erythematosus</dc:title><prism:publicationName>J Rheumatol</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>10</prism:volume><prism:startingPage>418</prism:startingPage><prism:endingPage>423</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0029089379"><api:scopusId>0029089379</api:scopusId><dc:title>Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus</dc:title><prism:publicationName>Am J Kidney Dis</prism:publicationName><prism:publicationYear>1995</prism:publicationYear><prism:volume>26</prism:volume><prism:startingPage>432</prism:startingPage><prism:endingPage>438</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/10444275010"><api:scopusId>10444275010</api:scopusId><dc:title>Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>50</prism:volume><prism:startingPage>3934</prism:startingPage><prism:endingPage>3940</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0345352680"><api:scopusId>0345352680</api:scopusId><dc:title>Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>12</prism:volume><prism:startingPage>287</prism:startingPage><prism:endingPage>296</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0030268581"><api:scopusId>0030268581</api:scopusId><dc:title>Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1996</prism:publicationYear><prism:volume>125</prism:volume><prism:startingPage>549</prism:startingPage><prism:endingPage>557</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2942731474"><api:scopusId>2942731474</api:scopusId><dc:title>Treatment for lupus nephritis</dc:title><prism:publicationName>Cochrane Database Syst Rev</prism:publicationName><prism:publicationYear>2004</prism:publicationYear></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0742278571"><api:scopusId>0742278571</api:scopusId><dc:title>Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials</dc:title><prism:publicationName>Am J Kidney Dis</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>43</prism:volume><prism:startingPage>197</prism:startingPage><prism:endingPage>208</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0022578857"><api:scopusId>0022578857</api:scopusId><dc:title>Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:volume>986</prism:volume><prism:startingPage>614</prism:startingPage><prism:endingPage>619</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035928643"><api:scopusId>0035928643</api:scopusId><dc:title>Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>135</prism:volume><prism:startingPage>248</prism:startingPage><prism:endingPage>257</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0026767866"><api:scopusId>0026767866</api:scopusId><dc:title>Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis</dc:title><prism:publicationName>Lancet</prism:publicationName><prism:publicationYear>1992</prism:publicationYear><prism:volume>340</prism:volume><prism:startingPage>741</prism:startingPage><prism:endingPage>745</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/25444432233"><api:scopusId>25444432233</api:scopusId><dc:title>Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>2761</prism:startingPage><prism:endingPage>2767</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034687429"><api:scopusId>0034687429</api:scopusId><dc:title>Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>343</prism:volume><prism:startingPage>1156</prism:startingPage><prism:endingPage>1162</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/20444466207"><api:scopusId>20444466207</api:scopusId><dc:title>Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis</dc:title><prism:publicationName>J Am Soc Nephrol</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>16</prism:volume><prism:startingPage>1076</prism:startingPage><prism:endingPage>1084</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/28144433147"><api:scopusId>28144433147</api:scopusId><dc:title>Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>353</prism:volume><prism:startingPage>2219</prism:startingPage><prism:endingPage>2228</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/28444437000"><api:scopusId>28444437000</api:scopusId><dc:title>Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis</dc:title><prism:publicationName>Nephrology (Carlton)</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>10</prism:volume><prism:startingPage>504</prism:startingPage><prism:endingPage>510</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/1442355581"><api:scopusId>1442355581</api:scopusId><dc:title>Sequential therapies for proliferative lupus nephritis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>350</prism:volume><prism:startingPage>971</prism:startingPage><prism:endingPage>980</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/32444443319"><api:scopusId>32444443319</api:scopusId><dc:title>The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>54</prism:volume><prism:startingPage>421</prism:startingPage><prism:endingPage>432</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/38749143287"><api:scopusId>38749143287</api:scopusId></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/28544449032"><api:scopusId>28544449032</api:scopusId><dc:title>B-cell depletion in the treatment of patients with systemic lupus erythematosus: A longitudinal analysis of 24 patients</dc:title><prism:publicationName>Rheumatology (Oxford)</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>1542</prism:startingPage><prism:endingPage>1545</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034007121"><api:scopusId>0034007121</api:scopusId><dc:title>Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide</dc:title><prism:publicationName>Kidney Int</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>57</prism:volume><prism:startingPage>258</prism:startingPage><prism:endingPage>264</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/13444259472"><api:scopusId>13444259472</api:scopusId><dc:title>Lupus nephritis flares</dc:title><prism:publicationName>Lupus</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>14</prism:volume><prism:startingPage>49</prism:startingPage><prism:endingPage>52</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0030198652"><api:scopusId>0030198652</api:scopusId><dc:title>End-stage renal disease and systemic lupus erythematosus</dc:title><prism:publicationName>Am J Med</prism:publicationName><prism:publicationYear>1996</prism:publicationYear><prism:volume>101</prism:volume><prism:startingPage>100</prism:startingPage><prism:endingPage>107</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0021733803"><api:scopusId>0021733803</api:scopusId><dc:title>Survival rates of 2,728 patients with end-stage renal disease</dc:title><prism:publicationName>Mayo Clin Proc</prism:publicationName><prism:publicationYear>1984</prism:publicationYear><prism:volume>59</prism:volume><prism:startingPage>776</prism:startingPage><prism:endingPage>783</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0020620634"><api:scopusId>0020620634</api:scopusId><dc:title>The clinical course of end-stage renal disease in systemic lupus erythematosus</dc:title><prism:publicationName>Arch Intern Med</prism:publicationName><prism:publicationYear>1983</prism:publicationYear><prism:volume>143</prism:volume><prism:startingPage>1353</prism:startingPage><prism:endingPage>1356</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035884699"><api:scopusId>0035884699</api:scopusId><dc:title>Outcome after transplantation of young patients with systemic lupus erythematosus: A report of the North American pediatric renal transplant cooperative study</dc:title><prism:publicationName>Transplantation</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>72</prism:volume><prism:startingPage>973</prism:startingPage><prism:endingPage>978</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0037673312"><api:scopusId>0037673312</api:scopusId><dc:title>Outcome of renal transplantation in patients with systemic lupus erythematosus</dc:title><prism:publicationName>Transpl Int</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>16</prism:volume><prism:startingPage>411</prism:startingPage><prism:endingPage>418</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/26944451361"><api:scopusId>26944451361</api:scopusId><dc:title>The long-term prognosis of renal transplantation in patients with lupus nephritis</dc:title><prism:publicationName>Am J Kidney Dis</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>45</prism:volume><prism:startingPage>903</prism:startingPage><prism:endingPage>911</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034021145"><api:scopusId>0034021145</api:scopusId><dc:title>Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis</dc:title><prism:publicationName>Kidney Int</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>57</prism:volume><prism:startingPage>2136</prism:startingPage><prism:endingPage>2143</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0032401856"><api:scopusId>0032401856</api:scopusId><dc:title>Graft loss and the antiphospholipid syndrome following liver transplantation</dc:title><prism:publicationName>J Hepatol</prism:publicationName><prism:publicationYear>1998</prism:publicationYear><prism:volume>29</prism:volume><prism:startingPage>999</prism:startingPage><prism:endingPage>1003</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033013573"><api:scopusId>0033013573</api:scopusId><dc:title>Antiphospholipid (aPL) antibodies in end-stage renal disease</dc:title><prism:publicationName>J Nephrol</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>12</prism:volume><prism:startingPage>89</prism:startingPage><prism:endingPage>94</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0036899604"><api:scopusId>0036899604</api:scopusId><dc:title>Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001</dc:title><prism:publicationName>Nephrol Dial Transplant</prism:publicationName><prism:publicationYear>2002</prism:publicationYear><prism:volume>17</prism:volume><prism:startingPage>2212</prism:startingPage><prism:endingPage>2219</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033518231"><api:scopusId>0033518231</api:scopusId><dc:title>Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>341</prism:volume><prism:startingPage>1725</prism:startingPage><prism:endingPage>1730</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77953582870"><api:scopusId>77953582870</api:scopusId><prism:publicationName>Appraisal of Guidelines for Research &amp; Evaluation</prism:publicationName><prism:publicationYear>2001</prism:publicationYear></rdf:Description></rdf:RDF>